Showing 1 - 5 of 5
New developments in anti-corruption compliance in Thailand
Business, Peerapan Tungsuwan, Published on 16/10/2017
» As in many countries around Asia, corruption is still a significant problem for Thailand. On the 2016 Corruption Perceptions Index compiled by Transparency International, Thailand ranked a poor 101st from a total of 176 nations.
Technology in Healthcare: the New Face of Healthcare Delivery
Business, Peerapan Tungsuwan, Published on 26/08/2017
» Technology in healthcare or for the sake of healthcare is not new. It has been around for many years. When we talk about technology in healthcare, it can mean many different things to different people. Terms such as healthtech, meditech and digital health all refer to much the same thing: the partnership between technology and healthcare.
Powering the future: The importance and protection of personal health information
Business, Peerapan Tungsuwan, Published on 11/09/2017
» In our previous article, we discussed some of the products that have been innovated, developed, manufactured, assembled and brought to market as a result of new technology, and some of the opportunities and legal implications for their use and regulation.
Powering the future of healthcare: Adapting to telemedicine
Business, Peerapan Tungsuwan, Published on 18/09/2017
» We are now moving to the second half of our series on healthcare. In the first four articles we provided an overview of the significance of technology in healthcare and how the partnership between technology and healthcare is evolving rapidly and fundamentally altering the nature of healthcare and the manner of its delivery. We suggested that Thailand needs to ensure that it keeps pace with these changes or it will run the risk of being left behind.
Price controls of new patented drugs a step in the wrong direction
Business, Peerapan Tungsuwan, Published on 01/06/2015
» In Thailand price controls of drugs have existed for a long time and in many forms. However, for the first time there is a proposal to include direct price control of new patented drugs as part of the approval and registration process.